Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entinostat + 5-Azacytidine Schedules in Elderly AML
NCT01305499Phase 2Active, not recruiting
- Start
- Jul 2011
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of entinostat in acute myeloid leukemia (AML). Started Jul 2011; status: active, not recruiting.
02
Drugs
entinostat
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT01305499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01305499.